Posted by Michael Wonder on 11 Nov 2019
Breast and kidney cancer drugs get approval for use across Scotland's NHS
11 November 2019 - Medicines for breast and kidney cancers are among five new drugs which can now be used across Scotland's NHS.
The Scottish Medicines Consortium announced it had accepted the use of the treatments today while it also rejected atezolizumab for tackling non-small cell lung cancer.
Many were given the green light following work carried out through the SMC's patient and clinician engagement (Pace) process.
